Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M

Laura Shawver, CEO of Silverback Therapeutics. (Silverback Photo)

Silverback Therapeutics plans to raise up to $151.8 million in its initial public offering, the Seattle-based company said Monday in an updated IPO filing.

The biotech firm will aim to sell 6.95 million shares at $17 to $19 per



from My reading List https://ift.tt/33whaNl

Comments

Popular posts from this blog

2 Steps for a Career Change

These Are The Best Universities in Northern Ireland for International students, 2021

The Future of Higher Education with Dr. Joseph Sallustio